Table of Contents

1. Introduction

 1.1 Peripheral Artery Disease Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Peripheral Artery Disease Market Snapshot

 2.2 Peripheral Artery Disease Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Peripheral Artery Disease Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 PAD Market Size By Type (Devices, Drugs)

  2.3.2 PAD Market Size By End-User (Hospitals, Specialty Clinics)

 2.4 Peripheral Artery Disease Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Peripheral Artery Disease Market Overview

 3.1 PAD Market Dynamics

  3.1.1 Drivers (Aging Population, Diabetes Prevalence)

  3.1.2 Restraints (High Cost of Endovascular Procedures, Misdiagnosis)

  3.1.3 Opportunities (Drug-Coated Balloons, Atherectomy Devices)

  3.1.4 Key PAD Market Trends (Minimally Invasive Surgeries, Bioresorbable Stents)

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting PAD Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers (Nitinol, Polymers, Drug Coatings)

  3.4.2 Manufacturers (Catheters, Stents, Balloons)

  3.4.3 Distributors/Specialty Wholesalers

  3.4.4 Hospitals & Vascular Clinics (End-Users)

 3.5 Industry Life Cycle Assessment (Growth Phase)

 3.6 Parent Cardiovascular Devices Market Overview

 3.7 PAD Market Risk Assessment (Device Recalls, Regulatory Delays)

4. Statistical Insights & Trends Reporting (PAD-Specific)

4.1 Clinical Trial & Treatment Outcome Metrics

  4.1.1 Overview

  4.1.2 Primary Patency Rates for Drug-Coated Balloons vs. Bare Metal Stents

  4.1.3 Major Amputation Rates by Region (CLI Patients)

  4.1.4 Six-Month Target Lesion Revascularization (TLR) Metrics

  4.1.5 Mortality Rates Post Endovascular vs. Surgical Bypass

4.2 Reimbursement & Cost-Effectiveness Landscape

  4.2.1 Overview

  4.2.2 Medicare & Private Payer Coverage for Atherectomy Devices

  4.2.3 Cost Comparison: Outpatient Endovascular Procedures vs. Inpatient Bypass Surgery

  4.2.4 Impact of ICD-10 Coding Changes on PAD Diagnosis Rates

  4.2.5 Value-Based Healthcare Models for Chronic PAD Management

4.3 Technology & Device Innovation Metrics

  4.3.1 Overview

  4.3.2 Adoption Rate of Drug-Eluting Stents (DES) in Femoropopliteal Arteries

  4.3.3 Investment in Intravascular Lithotripsy (IVL) for Calcified Plaques

  4.3.4 Patent Filings in Bioresorbable Vascular Scaffolds (BVS)

  4.3.5 Emerging Trends: AI-Powered Angiography, Robotic-Assisted Peripheral Interventions

4.4 Disease Burden & Diagnostic Metrics

  4.4.1 Overview

  4.4.2 Prevalence of Intermittent Claudication vs. Critical Limb Ischemia (CLI)

  4.4.3 Ankle-Brachial Index (ABI) Screening Rates in Primary Care

  4.4.4 Underdiagnosis Rates in Asymptomatic PAD Patients

  4.4.5 Correlation Between PAD Severity and Diabetes/Dyslipidemia Comorbidities

4.5 Investment & Strategic Activity in PAD Therapeutics

  4.5.1 Overview

  4.5.2 Venture Capital Funding for Gene Therapy in PAD (e.g., VEGF, FGF)

  4.5.3 Key M&A Activity (Stent Manufacturers Acquiring Thrombectomy Startups)

  4.5.4 Collaborations Between Device Makers and Imaging AI Firms

  4.5.5 Emerging R&D Hubs for Peripheral Vascular Interventions (Europe, USA, Japan)

5. Peripheral Artery Disease Market Segmental Analysis & Forecast, By Type, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Devices

  5.2.1 Key Trends (Miniaturization, Drug Coatings)

  5.2.2 PAD Market Size & Forecast (Stents, Balloons, Catheters, Atherectomy Devices), 2022–2035

 5.3 Drugs

  5.3.1 Key Trends (Novel Antithrombotics, Cilostazol Generics)

  5.3.2 PAD Market Size & Forecast (Antiplatelets, Statins, Thrombolytics), 2022–2035

6. Peripheral Artery Disease Market Segmental Analysis & Forecast, By End-User, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Hospitals

  6.2.1 Key Trends (Hybrid ORs for Complex PAD Cases)

  6.2.2 PAD Market Size & Forecast, 2022–2035

 6.3 Specialty Clinics (Ambulatory Surgical Centers / Vascular Centers)

  6.3.1 Key Trends (Outpatient Endovascular Procedures)

  6.3.2 PAD Market Size & Forecast, 2022–2035

7. Peripheral Artery Disease Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

7.1 Introduction

7.2 North America (USA, Canada)

 7.2.1 Key Trends (High adoption of DCBs, robust reimbursement)

 7.2.2 Market Size & Forecast By Type, End-User & Country

7.3 Europe (Germany, UK, France, Italy, Spain, Poland, Rest of Europe)

 7.3.1 Key Trends (Aging population, public health screening programs)

7.4 Asia-Pacific (China, India, Japan, South Korea, Australia, ASEAN, Rest of APAC)

 7.4.1 Key Trends (Rising diabetes rates, improving healthcare infrastructure)

7.5 Latin America (Brazil, Argentina, Mexico, Colombia, Rest of LATAM)

 7.5.1 Key Trends (Growing medical tourism for vascular surgeries)

7.6 Middle East & Africa (UAE, Saudi Arabia, Qatar, Egypt, South Africa, Rest of MEA)

 7.6.1 Key Trends (Increasing obesity rates, government investments in vascular care)

8. Competitive Landscape

 8.1 Key Players' Positioning (Medtronic, Abbott, Boston Scientific, BD, Cook, Cardinal, Terumo, Philips, BIOTRONIK, iVascular)

 8.2 Competitive Developments

  8.2.1 Key Strategies Adopted (%), By Key Players, 2025 (Product Launches, FDA Approvals)

  8.2.2 Year-Wise Strategies & Development, 2022–2025

  8.2.3 Number Of Strategies Adopted By Key Players, 2025

 8.3 PAD Market Share Analysis (Device vs. Drug Segment), 2025

 8.4 Product/Service & Application Benchmarking

  8.4.1 Device Specifications (Crossing profiles, drug dosage, delivery systems)

  8.4.2 Product/Service Heatmap By Key Players

  8.4.3 Application Heatmap (Claudication vs. CLI) By Key Players

 8.5 Industry Start-Up & Innovation Landscape (Early-stage atherectomy, cell therapy companies)

9. Key Company Profiles (Detailed)

9.1 Medtronic plc

 9.1.1 Company Overview & Snapshot

 9.1.2 Product/Service Portfolio (IN.PACT DCB, Abre Stent)

 9.1.3 Key Company Financials (Cardiovascular Portfolio)

 9.1.4 SWOT Analysis

9.2 Abbott Laboratories

9.3 Boston Scientific Corporation

9.4 Becton, Dickinson and Company (BD)

9.5 Cook Medical

9.6 Cardinal Health, Inc.

9.7 Terumo Corporation

9.8 Philips Healthcare

9.9 BIOTRONIK SE & Co. KG

9.10 iVascular S.L.U.

10. Analyst Recommendations

 10.1 SNS Insider Opportunity Map (Focus on DCBs, Emerging Markets)

 10.2 Industry Low-Hanging Fruit Assessment (Rural ABI Screening Programs)

 10.3 PAD Market Entry & Growth Strategy (Partnering with Vascular Societies)

 10.4 Analyst Viewpoint & Suggestions on PAD Market Growth (Focus on CLI therapies)

11. Assumptions

12. Disclaimer

13. Appendix

 13.1 List Of Tables

 13.2 List Of Figures